These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 26842600)

  • 1. Intracerebral Injection of Metal-Binding Domain of Aβ Comprising the Isomerized Asp7 Increases the Amyloid Burden in Transgenic Mice.
    Kulikova AA; Cheglakov IB; Kukharsky MS; Ovchinnikov RK; Kozin SA; Makarov AA
    Neurotox Res; 2016 May; 29(4):551-7. PubMed ID: 26842600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nitration of tyrosine 10 critically enhances amyloid β aggregation and plaque formation.
    Kummer MP; Hermes M; Delekarte A; Hammerschmidt T; Kumar S; Terwel D; Walter J; Pape HC; König S; Roeber S; Jessen F; Klockgether T; Korte M; Heneka MT
    Neuron; 2011 Sep; 71(5):833-44. PubMed ID: 21903077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peripherally Applied Synthetic Tetrapeptides HAEE and RADD Slow Down the Development of Cerebral β-Amyloidosis in AβPP/PS1 Transgenic Mice.
    Tsvetkov PO; Cheglakov IB; Ovsepyan AA; Mediannikov OY; Morozov AO; Telegin GB; Kozin SA
    J Alzheimers Dis; 2015; 46(4):849-53. PubMed ID: 26402624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intraperitoneal injection of the pancreatic peptide amylin potently reduces behavioral impairment and brain amyloid pathology in murine models of Alzheimer's disease.
    Zhu H; Wang X; Wallack M; Li H; Carreras I; Dedeoglu A; Hur JY; Zheng H; Li H; Fine R; Mwamburi M; Sun X; Kowall N; Stern RA; Qiu WQ
    Mol Psychiatry; 2015 Feb; 20(2):252-62. PubMed ID: 24614496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peripherally applied synthetic peptide isoAsp7-Aβ(1-42) triggers cerebral β-amyloidosis.
    Kozin SA; Cheglakov IB; Ovsepyan AA; Telegin GB; Tsvetkov PO; Lisitsa AV; Makarov AA
    Neurotox Res; 2013 Oct; 24(3):370-6. PubMed ID: 23670398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diversity in Aβ deposit morphology and secondary proteome insolubility across models of Alzheimer-type amyloidosis.
    Xu G; Fromholt SE; Chakrabarty P; Zhu F; Liu X; Pace MC; Koh J; Golde TE; Levites Y; Lewis J; Borchelt DR
    Acta Neuropathol Commun; 2020 Apr; 8(1):43. PubMed ID: 32252825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stromal cell-derived factor 1α decreases β-amyloid deposition in Alzheimer's disease mouse model.
    Wang Q; Xu Y; Chen JC; Qin YY; Liu M; Liu Y; Xie MJ; Yu ZY; Zhu Z; Wang W
    Brain Res; 2012 Jun; 1459():15-26. PubMed ID: 22560596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of phagocytic activity in astrocytes by reduced expression of the inflammasome component ASC and its implication in a mouse model of Alzheimer disease.
    Couturier J; Stancu IC; Schakman O; Pierrot N; Huaux F; Kienlen-Campard P; Dewachter I; Octave JN
    J Neuroinflammation; 2016 Jan; 13():20. PubMed ID: 26818951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of BACE1 haploinsufficiency on APP processing and Aβ concentrations in male and female 5XFAD Alzheimer mice at different disease stages.
    Devi L; Ohno M
    Neuroscience; 2015 Oct; 307():128-37. PubMed ID: 26314636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neprilysin deficiency alters the neuropathological and behavioral phenotype in the 5XFAD mouse model of Alzheimer's disease.
    Hüttenrauch M; Baches S; Gerth J; Bayer TA; Weggen S; Wirths O
    J Alzheimers Dis; 2015; 44(4):1291-302. PubMed ID: 25408216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alzheimer's Amyloid-β Sequesters Caspase-3 in Vitro via Its C-Terminal Tail.
    Chang YJ; Linh NH; Shih YH; Yu HM; Li MS; Chen YR
    ACS Chem Neurosci; 2016 Aug; 7(8):1097-106. PubMed ID: 27227450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High order W02-reactive stable oligomers of amyloid-β are produced in vivo and in vitro via dialysis and filtration of synthetic amyloid-β monomer.
    Robb E; Perez K; Hung LW; Masters CL; Barnham KJ; Cherny RA; Bush AI; Adlard PA; Finkelstein DI
    J Alzheimers Dis; 2015; 44(1):69-78. PubMed ID: 25182735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Geniposide attenuates insulin-deficiency-induced acceleration of β-amyloidosis in an APP/PS1 transgenic model of Alzheimer's disease.
    Zhang Y; Yin F; Liu J; Liu Z; Guo L; Xia Z; Zidichouski J
    Neurochem Int; 2015 Oct; 89():7-16. PubMed ID: 25882165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Murine Aβ over-production produces diffuse and compact Alzheimer-type amyloid deposits.
    Xu G; Ran Y; Fromholt SE; Fu C; Yachnis AT; Golde TE; Borchelt DR
    Acta Neuropathol Commun; 2015 Nov; 3():72. PubMed ID: 26566997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of amyloid-β deposits from serially transmitted, histologically silent, Aβ seeds issued from human brains.
    Hérard AS; Petit F; Gary C; Guillermier M; Boluda S; Garin CM; ; Lam S; Dhenain M
    Acta Neuropathol Commun; 2020 Nov; 8(1):205. PubMed ID: 33250056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipid oxidation and modification of amyloid-β (Aβ) in vitro and in vivo.
    Ellis G; Fang E; Maheshwari M; Roltsch E; Holcomb L; Zimmer D; Martinez D; Murray IV
    J Alzheimers Dis; 2010; 22(2):593-607. PubMed ID: 20847409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soluble Aβ levels correlate with cognitive deficits in the 12-month-old APPswe/PS1dE9 mouse model of Alzheimer's disease.
    Zhang W; Hao J; Liu R; Zhang Z; Lei G; Su C; Miao J; Li Z
    Behav Brain Res; 2011 Sep; 222(2):342-50. PubMed ID: 21513747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An age-related axon terminal pathology around the first olfactory relay that involves amyloidogenic protein overexpression without plaque formation.
    Cai Y; Xue ZQ; Zhang XM; Li MB; Wang H; Luo XG; Cai H; Yan XX
    Neuroscience; 2012 Jul; 215():160-73. PubMed ID: 22542680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for seeding of beta -amyloid by intracerebral infusion of Alzheimer brain extracts in beta -amyloid precursor protein-transgenic mice.
    Kane MD; Lipinski WJ; Callahan MJ; Bian F; Durham RA; Schwarz RD; Roher AE; Walker LC
    J Neurosci; 2000 May; 20(10):3606-11. PubMed ID: 10804202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amyloid Plaques Show Binding Capacity of Exogenous Injected Amyloid-β.
    Gureviciene I; Gurevicius K; Mugantseva E; Kislin M; Khiroug L; Tanila H
    J Alzheimers Dis; 2017; 55(1):147-157. PubMed ID: 27636846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.